172 related articles for article (PubMed ID: 18332165)
1. The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.
Gelhaus C; Jacobs T; Andrä J; Leippe M
Antimicrob Agents Chemother; 2008 May; 52(5):1713-20. PubMed ID: 18332165
[TBL] [Abstract][Full Text] [Related]
2. NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi.
Jacobs T; Bruhn H; Gaworski I; Fleischer B; Leippe M
Antimicrob Agents Chemother; 2003 Feb; 47(2):607-13. PubMed ID: 12543667
[TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis.
Ghosh JK; Shaool D; Guillaud P; Cicéron L; Mazier D; Kustanovich I; Shai Y; Mor A
J Biol Chem; 1997 Dec; 272(50):31609-16. PubMed ID: 9395500
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for membrane selectivity of NK-2, a potent peptide antibiotic derived from NK-lysin.
Schröder-Borm H; Willumeit R; Brandenburg K; Andrä J
Biochim Biophys Acta; 2003 Jun; 1612(2):164-71. PubMed ID: 12787934
[TBL] [Abstract][Full Text] [Related]
5. Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin.
Andrä J; Leippe M
Med Microbiol Immunol; 1999 Dec; 188(3):117-24. PubMed ID: 10776841
[TBL] [Abstract][Full Text] [Related]
6. Chicken NK-lysin is an alpha-helical cationic peptide that exerts its antibacterial activity through damage of bacterial cell membranes.
Lee MO; Jang HJ; Han JY; Womack JE
Poult Sci; 2014 Apr; 93(4):864-70. PubMed ID: 24706963
[TBL] [Abstract][Full Text] [Related]
7. Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens.
Andrä J; Monreal D; Martinez de Tejada G; Olak C; Brezesinski G; Gomez SS; Goldmann T; Bartels R; Brandenburg K; Moriyon I
J Biol Chem; 2007 May; 282(20):14719-28. PubMed ID: 17389605
[TBL] [Abstract][Full Text] [Related]
8. Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture.
Efron L; Dagan A; Gaidukov L; Ginsburg H; Mor A
J Biol Chem; 2002 Jul; 277(27):24067-72. PubMed ID: 11937508
[TBL] [Abstract][Full Text] [Related]
9. Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.
Love MS; Millholland MG; Mishra S; Kulkarni S; Freeman KB; Pan W; Kavash RW; Costanzo MJ; Jo H; Daly TM; Williams DR; Kowalska MA; Bergman LW; Poncz M; DeGrado WF; Sinnis P; Scott RW; Greenbaum DC
Cell Host Microbe; 2012 Dec; 12(6):815-23. PubMed ID: 23245326
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion.
Bianchin A; Bell A; Chubb AJ; Doolan N; Leneghan D; Stavropoulos I; Shields DC; Mooney C
PLoS One; 2015; 10(6):e0127383. PubMed ID: 26039561
[TBL] [Abstract][Full Text] [Related]
11. In vitro antiplasmodium effects of dermaseptin S4 derivatives.
Dagan A; Efron L; Gaidukov L; Mor A; Ginsburg H
Antimicrob Agents Chemother; 2002 Apr; 46(4):1059-66. PubMed ID: 11897590
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of bovine NK-lysin-derived peptides on Mycoplasma bovis.
Dassanayake RP; Falkenberg SM; Register KB; Samorodnitsky D; Nicholson EM; Reinhardt TA
PLoS One; 2018; 13(5):e0197677. PubMed ID: 29771981
[TBL] [Abstract][Full Text] [Related]
13. Anti-Plasmodium activity of ceramide analogs.
Labaied M; Dagan A; Dellinger M; Gèze M; Egée S; Thomas SL; Wang C; Gatt S; Grellier P
Malar J; 2004 Dec; 3():49. PubMed ID: 15588325
[TBL] [Abstract][Full Text] [Related]
14. Identification of peptides targeting the surface of Plasmodium falciparum-infected erythrocytes using a phage display peptide library.
Eda K; Eda S; Sherman IW
Am J Trop Med Hyg; 2004 Aug; 71(2):190-5. PubMed ID: 15306709
[TBL] [Abstract][Full Text] [Related]
15. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine.
Schröder-Borm H; Bakalova R; Andrä J
FEBS Lett; 2005 Nov; 579(27):6128-34. PubMed ID: 16269280
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial activities of dermaseptin S4 derivatives.
Krugliak M; Feder R; Zolotarev VY; Gaidukov L; Dagan A; Ginsburg H; Mor A
Antimicrob Agents Chemother; 2000 Sep; 44(9):2442-51. PubMed ID: 10952593
[TBL] [Abstract][Full Text] [Related]
17. A De novo Peptide from a High Throughput Peptide Library Blocks Myosin A -MTIP Complex Formation in
Anam ZE; Joshi N; Gupta S; Yadav P; Chaurasiya A; Kahlon AK; Kaushik S; Munde M; Ranganathan A; Singh S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32859024
[TBL] [Abstract][Full Text] [Related]
18. Vesicle-mediated trafficking of parasite proteins to the host cell cytosol and erythrocyte surface membrane in Plasmodium falciparum infected erythrocytes.
Taraschi TF; Trelka D; Martinez S; Schneider T; O'Donnell ME
Int J Parasitol; 2001 Oct; 31(12):1381-91. PubMed ID: 11566305
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of malaria parasite Plasmodium falciparum development by crotamine, a cell penetrating peptide from the snake venom.
El Chamy Maluf S; Dal Mas C; Oliveira EB; Melo PM; Carmona AK; Gazarini ML; Hayashi MA
Peptides; 2016 Apr; 78():11-6. PubMed ID: 26806200
[TBL] [Abstract][Full Text] [Related]
20. Identification of Antimalarial Compounds That Require CLAG3 for Their Uptake by
Mira-Martínez S; Pickford AK; Rovira-Graells N; Guetens P; Tintó-Font E; Cortés A; Rosanas-Urgell A
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
